期刊文献+

葡甘聚糖对Caco-2细胞中二肽基肽酶Ⅳ抑制作用的研究

Glucomannan inhibit dipeptidyl peptidase 4 (DPP4) activity in the Caco-2 cell
下载PDF
导出
摘要 目的:研究不同浓度葡甘聚糖作用长、短不同时间对Caco-2细胞中二肽基肽酶Ⅳ(dipeptidyl peptidase 4,DPP4)的抑制作用。方法:实验分为葡甘聚糖60、240 mg/L两个低浓度梯度组,400、500 mg/L两个中浓度梯度组,700、800、900 mg/L 3个高浓度梯度组,阴性对照组和空白对照组。各实验组分别单独作用于Caco-2细胞12 h和36 h,采用以甘氨酰脯氨酸对硝基苯胺(Gly-Pro-pNA)为底物的发色底物法检测不同浓度葡甘聚糖对体外Caco-2细胞中DPP-Ⅳ活性的影响。结果:(1)低、中、高浓度梯度的葡甘聚糖短时间(12 h)作用于Caco-2细胞后,与阴性对照组相比较得到P值,低浓度梯度组分别为0.579、0.545,中浓度梯度组分别为0.349、0.080,高浓度梯度组分别为0.082、0.097、0.429,差异均无统计学意义(P>0.05)。(2)低、中、高浓度梯度的葡甘聚糖长时间(36 h)作用于Caco-2细胞后,与阴性对照组相比较得到P值,低浓度梯度组分别为0.007、0.002,中浓度梯度组分别为0.621、0.976,高浓度梯度组分别为1.000、0.940、0.994,低浓度梯度组与阴性对照组相比较差异具有统计学意义(P<0.05)。结论:不同浓度葡甘聚糖短时间(12 h)作用于Caco-2细胞后,700 mg/L的高浓度葡甘聚糖对Caco-2细胞中DPP-Ⅳ活性有一定的抑制作用趋势;长时间(36 h)作用于Caco-2细胞后,60、240 mg/L的低浓度葡甘聚糖能够抑制Caco-2细胞中DPP-Ⅳ活性。 AIM: To observe the inhibitory effect of different concentration of Glucomannan on dipeptidyl peptidase 4 activity in the Caco-2 cell at 12 h, 36 h, respectively. METHODS: Seven different concentrations were tested in this experiment, two low concentration groups (60, 240 mg/L), two middle concentration groups (400, 500 mg/L), three high concentration groups(700, 800, 900 mg/L) of Glucomannan, negative control group, and blank control group. Each treatment lasted for 12 hours and 36 hours respectively. DPP4 activity was measured with colorimetric determination of product formation ( HGly-Pro-pNA, 0.2 mmol/L, Bachem) in different situations. RESULTS: (1) Compared with the negative control group, the P values of the different concentrations of glucomannan were 0. 579, 0. tion groups), 0. 349, 0. tration groups), 0. 082, Concentrations groups) 545 (the low concentration (the middle concen- 0. 097, 0. 429(the high respectively after reacting with Caco-2 cells for a short of time. There were no significant differences detected. (2) At 36 h, the P values were 0.007, 0.002 (the low concentration groups), 0. 621, 0. 976(the middle concentration groups), 1.000, 0.940, 0.994 (the high concentrations groups) respectively. The differences between the negative control groups and the low concentration groups have statistical significance ( P 〈 0.05 ). CONCLUSION: There is a trend indicating that the high concentrations of glucomannan (700 mg/L) may inhibit the DPP4 activity in Caco-2 cells at 12 h. However, under the same circumstance, the low concentration of glucomannan (60, 240 mg/L) can inhibit the DPP4 activity in Caco-2 cells in a long term (36 h).
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第7期754-758,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 葡甘聚糖 CACO-2细胞 二肽基肽酶Ⅳ 抑制作用 Glucomannan Caco-2 cell Dipeptidyl peptidase Ⅳ Inhibitory effect
  • 相关文献

参考文献14

  • 1Doi K. Effect of konjac fibre (glucomannan) on glu- cose and lipids[J]. Eur J Clin Nutr, 1995, 49 (333) : 8190-197.
  • 2Vuksan V, Sievenpiper JL, Owen R, et al. Benefi- cial effects of viscous dietary fiber from Konjac- mannan in subjects with the insulin resistance syn- drome: results of a controlled metabolic trial[J]. Diabetes Care, 2000, 23(1): 9-14.
  • 3Yoshida M, Sawa J, Hozumi T, et al. Effects of long-term high-fiber diet on macrovascular changes and lipid and glucose levels in STZ-induced diabetic SD rats[J]. Diabetes Res Clin Pract, 1991, 13(3): 147-152.
  • 4Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac- mannan (glucomannan) improves glycemia and oth- er associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled meta- bolictrial[J]. Diabetes Care, 1999, 22(6): 913- 919.
  • 5Yoshida M, Vanstone CA, Parsons WD, et al. Effect of plant sterols and glucomannan on lipids inindividuals with and without type II diabetes[J]. Eur J Clin Nutr, 2006, 60(4): 529-537.
  • 6王小燕,顾耀,闵旸,盛雨辰.葡甘聚糖对四氧嘧啶糖尿病模型大鼠的疗效观察[J].上海医学,2005,28(5):406-411. 被引量:6
  • 7向明,张晓煜,伍三兰,谷江霞,雷伯开,王玉洁,卓恩挺.魔芋葡甘聚糖对链脲霉素致大鼠糖尿病的防治作用[J].中国医院药学杂志,2005,25(3):223-225. 被引量:11
  • 8Deacon CF. Therapeutic strategies based on gluca- gon-like peptide [J]. Diabetes, 2004, 53(9): 2181 - 2189.
  • 9顿新鹏,陈正望.胰高血糖素样肽1及其修饰物的生理作用与临床应用[J].中华内分泌代谢杂志,2005,21(3):288-291. 被引量:6
  • 10Hansotia T, Drucker DJ. GIP and GLP-1 as incre- tin hormones: lessons from single and double incre- tin receptor knockout mice[J]. Regul Pept, 2005,128(2): 125-134.

二级参考文献62

  • 1丁伟平,杨金奎.魔芋多糖胶囊对糖尿病模型动物降血糖作用的实验研究[J].江苏预防医学,1996,7(1):16-19. 被引量:3
  • 2成惠林.检测细胞活性的MTT方法[J].江苏医药,1996,22(5):330-331. 被引量:15
  • 3苏衍进,祝海滨.茯神汤方治疗糖尿病38例临床体会[J].陕西中医学院学报,2006,29(3):21-22. 被引量:9
  • 4马宇鹏,张中新,张延英,李继霞,李广远.中药降糖胰生胶囊对实验性糖尿病动物模型的影响[J].第四军医大学学报,2006,27(13):1160-1162. 被引量:7
  • 5刘彬,齐云,王敏,蔡润兰,宋杨.一种磷脂酶A_2抑制剂体外筛选方法的建立[J].中国药理学通报,2006,22(7):890-892. 被引量:5
  • 6Holst J J, Deacon C F. Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus [ J ]. Curr Opin Pharmacol,2004,4:589 - 96.
  • 7Nagatsu T, Hino M, Fuyamada H, et at. New chromogenicsubstratesfor x-prolyldipeptidyl -aminopeptidase [ J]. Anal Biochem, 1976,74:466 - 76.
  • 8Pascual I, Lopez A, Gomez H, et al. Screening of inhibitors of porcine dipeptidyl peptidase IV activity in aqueous extracts from marine organisms[ J]. Enzyme Microb Technol ,2007 , 40 :414 - 9.
  • 9Nobuyuki Y, Tadashi N, Takashi I, et al. E3024,3-but-2-ynyl-5- methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [ 4,5-d] pyridazin-4-one tosylate, is a novel, selective and eompetitivedipeptidylpeptidase- Ⅳ inhibitor [ J ]. Eur J Pharmacol,2006,548 : 181 - 7.
  • 10Inger B,Jurgen J, Xin C, et al. IV catalyzed peptide truncation Inhibition of dipeptidyl-peptidase by Vildagliptin ( ( 2S ) - / [ ( 3- hydroxyadamantan-1-yl) amino { acetyl } -pyrrolidine-2-carbonitrile ] [ J ]. Biochemical pharmacology, 2005,70 : 134 - 43.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部